Published Date: 14 Mar 2023
According to market research firm Euromonitor, the global children's cough, cold and allergy products market in 2022 is worth $2.5 billion.
Read Full NewsThe FDA is requiring new labeling across all GLP-1 receptor agonists to warn of a potential increased risk of a rare, vision-threatening optic nerve condition.
David Leehey, MD, says about half of the 2376 enrolled veterans were taking an SGLT2 inhibitor at baseline.
1.
New Immune Therapy Boosts Disease Control in Prostate Cancer
2.
Talquetamab Regimens Boost Survival in Multiple Myeloma
3.
Treatment of Smoldering Myeloma Cuts Progression Rate in Half
4.
Alternative breast imaging techniques beyond mammography.
5.
In KRAS-mutated non-small cell lung cancer, glecirasib exhibits promising efficacy.
1.
Coagulation Factor Consumption During Severe Inflammation: Mechanisms, Clinical Implications, and Advances
2.
Precision Oncology: How Personalized Medicine is Transforming Cancer Treatment
3.
Coordinated Monitoring Pathways for Hematologic Disorders
4.
Alectinib in Resected ALK-Positive Non-Small-Cell Lung Cancer
5.
Modern Techniques in Hematology Across Clinical Settings
1.
International Conference on Innovations in Critical Care for Oncology and Cardiology
2.
International Conference on Oncology, Cardiology and Critical Care Policy
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
1.
INO-VATE: The Long-Term Overall Survival Analysis in Iontuzumab-Treated Patients
2.
Understanding Early Relapse in B-cell ALL: Rates, Risks, and Common Sites
3.
Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part I
4.
Navigating the Complexities of Ph Negative ALL - Part VII
5.
Pazopanib Takes Center Stage in Managing Renal Cell Carcinoma - Part II
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation